NCT06571747View on ClinicalTrials.gov

Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement

NAActive, not recruitingINTERVENTIONAL
Enrollment

3,668,428

Participants

Timeline

Start Date

September 5, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

March 31, 2026

Conditions
Cardiovascular DiseasesInfluenzaBehavior, Social
Interventions
BEHAVIORAL

Cardiovascular-Focused Nudge Communication

Intervention arms will receive a behavioral economic rooted nudge communication highlighting the potential cardiovascular benefits of vaccination.

Trial Locations (2)

20852

Kaiser Permanente Mid Atlantic States, Bethesda

94588

Kaiser Permanente Northern California, Pleasanton

All Listed Sponsors
lead

Kaiser Permanente

OTHER